Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
2d
Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
News Medical on MSN
New CRISPR Tool Sharpens Liquid Biopsy Cancer Detection
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...
In the past twenty years, major technological advances in extracting and analyzing DNA have transformed the ability to ...
First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...
Comparing proteomics to genomics reveals essential insights into their contributions to systems biology and experimental ...
NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback